Revenio Group Oyj (HEL: REG1V)
Finland flag Finland · Delayed Price · Currency is EUR
33.80
+0.40 (1.20%)
Aug 30, 2024, 6:29 PM EET

Revenio Group Oyj Company Description

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally.

The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel.

It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images.

In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities.

Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

Revenio Group Oyj
Country Finland
Founded 2001
Industry Medical Devices
Sector Healthcare
Employees 229
CEO Jouni Toijala

Contact Details

Address:
Äyritie 22
Vantaa, 01510
Finland
Phone 358 9877 51150
Website reveniogroup.fi

Stock Details

Ticker Symbol REG1V
Exchange Nasdaq Helsinki
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FI0009010912
SIC Code 7373

Key Executives

Name Position
Jouni Toijala B.Sc., M.B.A. President and Chief Executive Officer
Robin Pulkkinen M.Sc., M.Sc. (Econ) Chief Financial Officer
Ari Isomäki Vice President of Operations
Tomi Karvo M.B.A., M.Sc. Vice President of Products, Brand and Marketing
John Floyd Vice President of Sales
Hanna Vuornos Vice President of People and Culture
Kate Taylor Vice President of Strategy and Business Development